DISCLOSURES

Composition of the Board and Key Management Personnel | Composition of various committees | Code of Conduct for BoD and Senior Management personnel |

Terms and conditions for appointment of Independent Directors |Familiarization Programmes imparted to Independent Directors | Nomination and Remuneration Policy |

Related Party Transactions Policy| Material Subsidiaries Policy | Vigil Mechanism / Whistle Blower Policy | Materiality of Events Policy and Authorized KMPs |

Policy for Preservation of Documents

CORPORATE GOVERNANCE POLICIES

SCHEME OF AMALGAMATION 2018

Draft Scheme | Letter of observation - BSE |Notice of the shareholder meeting convened by NCLT | NCLT Certificate | NCLT Common Order | Shareholding pattern after share transfer

FINANCIAL RESULTS

Quarter ending 30th June

Quarter and Half year ending 30th September

Quarter ending 31st December

Quarter and Year ending 31st March

ANNUAL REPORT

2023 | 2022 | 2021 | 2020 | 2019 | 2018

2022 | 2021 | 2020 | 2019 | 2018

2022 | 2021 | 2020 | 2019 | 2018

2023 | 2022 | 2021 | 2020 | 2019

2022-23 | 2021-22 | 2020-21 | 2019-20 | 2019-20 merged | 2018-19 | 2018-19 merged | 2017-18

INVESTOR CORRESPONDENCE ADDRESS

Investor Grievance Contact

Mr. Rajesh Kumar Sundarray, Company Secretary

Phone No.: +91-44-22502146

E-mail: cs@indrayani.com; indrayanichennai@gmail.com

Secretarial Department, Indrayani Biotech Limited

CIN : L40100TN1992PLC129301

Regd.Office: Module# 32, 33, Block-1,

SIDCO Electronics Complex, Thiru Vi Ka Industrial Estate,

Guindy, Chennai - 600 032, Tamil Nadu, India

Registrar and Share Transfer Agent

Link Intime (India) Private Limited

Surya 35, Mayflower Avenue, Behind Senthil Nagar,

Sowripalayam Road, Coimbatore - 641028,

Tamil Nadu, India

Phone No.: +91-422-2314792

E-mail: Coimbatore@linkintime.co.in

Website: www.linkintime.co.in